258 filings
Page 5 of 13
8-K
pmsp nmzfy
6 Nov 19
Acceleron Reports Third Quarter 2019 Operating and Financial Results
7:54am
8-K
z2txkgqv67 lvcz5qj05
16 Sep 19
Acceleron Announces Topline Results from the Phase 2 Trial of ACE-083 in Patients with Facioscapulohumeral Muscular Dystrophy
5:12pm
8-K
5z3lhf3
5 Aug 19
Acceleron Reports Second Quarter 2019 Operating and Financial Results
4:09pm
CT ORDER
h90ce3gkowm
5 Jul 19
Confidential treatment order
9:51am
8-K
0zqjxl7
10 Jun 19
Departure of Directors or Certain Officers
4:47pm
8-K
k5uemr9mocw4ec4jlq
7 Jun 19
Other Events
4:06pm
8-K
kxl4e1vn iwcviso
9 May 19
Acceleron Reports First Quarter 2019 Operating and Financial Results
4:09pm
DEFA14A
5v8qjsieg1
12 Apr 19
Additional proxy soliciting materials
4:22pm
8-K
joord
5 Apr 19
Acceleron Discontinues Development of Phase 1 Molecule ACE-2494
5:19pm
S-8
idd17
27 Feb 19
Registration of securities for employees
4:28pm
8-K
5v0fhs9z 8h
27 Feb 19
Acceleron Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
4:12pm
8-K
l2q9adqzcj mtd
17 Jan 19
Other Events
12:00am
424B2
1oqoam
17 Jan 19
Prospectus for primary offering
12:00am
424B5
om9hcza3w24vzu
14 Jan 19
Prospectus supplement for primary offering
5:29pm
8-K
3xruwml9 iue61
7 Jan 19
Regulation FD Disclosure
7:17am
8-K
5bbes5xx
3 Dec 18
Regulation FD Disclosure
8:34am